Altre malattie infettive

DiaSorin offre una linea completa di test per le malattie infettive, basata su tecnologia ELISA e disponibile sui sistemi LIAISON®.

LIAISON® Measles IgM

The LIAISON® Measles IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to measles virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to measles virus. The test has to be performed on the LIAISON® analyzer family.

LIAISON® Measles IgG

The LIAISON® Measles IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi-quantitative determination of specific IgG antibodies to measles virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to measles virus. The test has to be performed on the LIAISON® analyzer family.

LIAISON® Mumps IgG

The LIAISON® Mumps IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi-quantitative determination of specific IgG antibodies to mumps virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to mumps virus. The test has to be performed on the LIAISON® analyzer family.

 

LIAISON® Mumps IgM

The LIAISON® Mumps IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to mumps virus in human serum or plasma samples. It is intended to be used as an aid in the determination of serological status to mumps virus. The test has to be performed on the LIAISON® analyzer family.

LIAISON® VZV IgG

The LIAISON® VZV IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to varicella-zoster virus (VZV) in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family.

LIAISON® VZV IgM

The LIAISON® VZV IgM assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgM antibodies to varicella-zoster virus (VZV) in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family.

LIAISON® Treponema Screen

The LIAISON® Treponema Screen assay uses chemiluminescent immunoassay (CLIA) technology for the qualitative determination of specific total antibodies to Treponema pallidum in human serum or plasma samples. The test has to be performed on the LIAISON® analyzer family.

Discover VZV Scientific booklet
LIAISON® XL MUREX Chagas

The LIAISON® XL MUREX Chagas is a chemiluminescence immunoassay (CLIA) for the qualitative detection of antibodies to Trypanosoma cruzi (T. cruzi) in human serum and plasma. The assay is intended to screen individual human donors for the presence of antibodies to T. cruzi or as an aid for the diagnosis of Chagas disease. The test has to be performed on the LIAISON® XL Analyzers only.

LIAISON® H. pylori IgG

The LIAISON® H. pylori IgG kit uses chemilumineshent immunoassay (CLIA) technology for the qualitative determination of IgG antibodies to Helicobacter pylori in human serum samples.
The test has to be performed on the LIAISON® Analyzer family.

Discover Syphilis Scientific booklet
LIAISON® Chlamydia trachomatis IgG

The LIAISON® Chalmydia trachomatis IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi-quantitative determination of specific IgG antibodies to Chlamydia trachomatis in human serum or plasma samples.
The test has to be performed on the LIAISON® analyzer family.

LIAISON® Chlamydia trachomatis IgA

The LIAISON® Chalmydia trachomatis IgA assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of specific IgG antibodies to Chlamydia trachomatis in human serum or plasma samples.
The test has to be performed on the LIAISON® analyzer family.

ADENOVIRUS IgA
ADENOVIRUS IgG
ADENOVIRUS IgM
ASCARIS LUMBRICOIDES IgG
B. BURGDORFERI IgG
B. BURGDORFERI IgM
BORDETELLA PERTUSSIS toxin IgA
BORDETELLA PERTUSSIS toxin IgG
BORDETELLA PERTUSSIS toxin IgM
BRUCELLA IgG
BRUCELLA IgM
CANDIDA ALBICANS IgA
CANDIDA ALBICANS IgG
CANDIDA ALBICANS IgM
CHAGAS (Tripanosoma cruzi) IgG
CHLAMYDIA IgA
CHLAMYDIA IgG
CHLAMYDIA IgM
CHLAMYDIA Pneumoniae IgA
HERPES SIMPLEX VIRUS TYPE 1 IgG
CHLAMYDIA Pneumoniae IgG
HERPES SIMPLEX VIRUS TYPE 1 IgM
CHLAMYDIA Pneumoniae IgM
HERPES SIMPLEX VIRUS TYPE 2 IgM
CHLAMYDIA Trachomatis IgA
CHLAMYDIA Trachomatis IgM
CLOSTRIDIUM TETANI 5s IgG
CLOSTRIDIUM TETANI 5s IgG PLUS
CLOSTRIDIUM TETANI IgG
CORYNEBACTERIUM DIPHTHERIAE 5S IgG
CORYNEBACTERIUM DIPHTHERIAE IgG
CORYNEBACTERIUM DIPHTHERIAE 5S IgGPLUS
COXIELLA burnetii Phase 2 IgG
COXIELLA burnetii Phase 1 IgG
COXIELLA burnetii Phase 2 IgM
DENGUE IgG
DENGUE IgM
ECHINOCOCCUS IgG
ENTAMOEBA HISTOLYTICA IgG (Amebiasis)
HELICOBACTER PYLORI IgA
HELICOBACTER PYLORI IgA PLUS
HELICOBACTER PYLORI IgG
HELICOBACTER PYLORI IgG PLUS
INFLUENZA A IgA
INFLUENZA A IgG
INFLUENZA A IgM
INFLUENZA B IgA
INFLUENZA B IgG
INFLUENZA B IgM
LEISHMANIA IgG
MEASLES IgG
MEASLES IgM
MUMPS IgG
MUMPS IgM
MYCOPLASMA PNEUMONIAE IgA
MYCOPLASMA PNEUMONIAE IgG
MYCOPLASMA PNEUMONIAE IgM
PARAINFLUENZA 1,2,3 IgA
PARAINFLUENZA 1,2,3 IgG
RESPIRATORY SYNCITIAL VIRUS IgA
RESPIRATORY SYNCITIAL VIRUS IgG
RESPIRATORY SYNCITIAL VIRUS IgM
SCHISTOSOMA MANSONI IgG
TAENIA SOLIUM IgG
TICK-BORNE ENCEPHALITIS VIRUS IgG
TICK-BORNE ENCEPHALITIS VIRUS IgG PLUS
TICK-BORNE ENCEPHALITIS VIRUS IgM
TOXOCARA CANIS IgG
TRICHINELLA SPIRALIS IgG
VARICELLA IgA
VARICELLA IgG
VARICELLA IgM
Parvovirus B19 IgG EIA
Parvovirus B19 IgM EIA

 

L’uso della sierologia è estremamente importante nella diagnosi di malattie in pazienti immunosoppressi e trapiantati, quando la determinazione dello stato immunitario risulta essere fondamentale; in questi pazienti, la sierologia infettiva può anche essere di aiuto per monitorare il decorso della malattia durante la terapia immunosoppressiva.
Altri marker sierologici (anticorpi contro VZV, Treponema pallidum, morbillo e parotite e molti altri) sono di fondamentale importanza per un’accurata diagnosi. Per anni, la stessa varietà di prodotti, unita alla distribuzione di una vasta lista di altri test sierologici, è stata realizzata per le micropiastre della tecnologia ELISA e alcuni di questi test sono realizzati per utilizzare la tecnologia chemiluminescente dei sistemi completamente automatizzati.